Andrew Casey, President and CEO of BIOTECanada, the national biotech association, provides an update on the Canadian biotech landscape, the strength of the Canadian R&D ecosystem, the growing investor community (both Canadian and foreign) looking to Canada as an untapped land of opportunities, and his hope to position Canada as one of the top three biotech ecosystems globally.
Andrew, when we met in 2013, you gave us a brief overview of the challenges and opportunities within the biotech landscape in Canada. How have things changed in the past four years since we last met you?
"If Canada is to be a competitive hotel, then the best amenities take the form of competitive IP regimes, tax policy, streamlined regulatory systems – the public policy equivalents of free wi-fi, free breakfast and rewards programs!"
